I Love My Pharmacist Award 2016 launched to find ‘unsung pharmacy heroes’ For the first time, this years’ I Love My Pharmacist Award, launched on 18 April, enables members of the public to nominate their favourite pharmacist. …
New small molecule drug shows promise in refractory rheumatoid arthritis Rheumatoid arthritis patients who do not respond to treatment with biologic therapies may find relief in baricitinib, a new small molecule drug, according to the results of a phase III study published in The New England Journal of Medicine.…
The man who discovered ibuprofen Ibuprofen is one of the world’s best selling anti-inflammatory painkillers. Its pioneer, Stewart Adams, now 92 years old, tells Julia Robinson about how and why his discovery came to fruition.…
Case study: management and counselling of a patient with rheumatoid arthritis Exploring questions to be considered when managing a patient with rheumatoid arthritis.…
Biosimilar medicines in rheumatology The long-term safety of biosimilar medicines is unknown, but while their use in rheumatology practice is supported, switching patients currently responding and tolerating the reference product is not.…
Department of Health reports 5.2% growth in spending on branded drugs NHS spending on branded drugs made available under the Pharmaceutical Price Regulation Scheme between 2013 and 2014 went up by 5.2%, according to a new analysis.…
Sir Gordon Hobday (1916–2015) Research chemist Sir Gordon Hobday was instrumental in the development of the anti-inflammatory drug ibuprofen and had a long career at Boots before becoming chairman.…
Response to hepatitis B vaccination impaired in rheumatoid arthritis patients Most rheumatoid arthritis patients taking immune-suppressant drugs do not have an adequate response to hepatitis B vaccination.…
Biological agents can reduce work absenteeism in patients with rheumatic disease Patients with rheumatic disease who are treated with biological drugs miss fewer days of work and are more productive than patients treated with non-biological agents, reveals a meta-analysis. …
Injection of modified cells reduces inflammation in arthritis sufferers A single injection of a patient’s own modified dendritic cells appears to be safe and to have anti-inflammatory and immunoregulatory effects in rheumatoid arthritis.…
